Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $700K in Market Capitalization this April of 2024, considering the latest stock price and the number of outstanding shares.Data for Adamis Pharmaceuticals | ADMP - Market Capitalization including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $1.24M in Stock for its fiscal quarter ending in December of 2022. Data for Adamis Pharmaceuticals | ADMP - Stock including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $0 in Loan Capital for its fiscal quarter ending in March of 2022. Data for Adamis Pharmaceuticals | ADMP - Loan Capital including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterNon-traditional data signals from social media and employment platforms for ADMP stock analysis
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $9.08M in Assets for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Assets including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $-8.94M in Net Income for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Net Income including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported 10.1M in Outstanding Shares in April of 2024. Data for Adamis Pharmaceuticals | ADMP - Outstanding Shares including historical, tables and charts were last updated by Trading Economics this last November in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $1.85M in Debt for its fiscal quarter ending in March of 2022. Data for Adamis Pharmaceuticals | ADMP - Debt including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
Twitterhttps://creativecommons.org/publicdomain/zero/1.0/https://creativecommons.org/publicdomain/zero/1.0/
This dataset contains 20 years of various MNC's stocks
This dataset contains 20 years of various MNC's stocks data is collected by scraping Yahoo Finance using python. Below are the MNCs whose stock data is in our dataset : 'Adamis Pharmaceuticals Corporation', 'Alphabet Inc.', 'Tata Consultancy Services Limited', 'Tata Motors Limited', 'Infosys Limited', 'Amazon.com, Inc.', 'Microsoft Corporation',' Facebook, Inc.', 'Intel Corporation', 'International Business Machines Corporation', 'Wipro Limited', 'The Walt Disney Company', 'Reliance Industries Limited', 'Lennar Corporation', 'Indian Railway Catering & Tourism Corporation Limited'
I created this dataset by scraping Yahoo Finance, I thank Yahoo Finance for providing such a platform
This is a stock dataset of various MNCs. This dataset will help you to analyze the stock and its features. It also helps you for forecasting purposes. If you like please upvote and feel free to comment, I hope this helps you. Thank you!
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $-6.32M in EBITDA for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Ebitda including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $9.78M in Trade Creditors for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Trade Creditors including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $10 in Interest Income for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Interest Income including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $21.17K in Trade Debtors for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Trade Debtors including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported 0 in Dividend Yield for its fiscal quarter ending in September of 2023. Data for Adamis Pharmaceuticals | ADMP - Dividend Yield including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $12.95M in Current Liabilities for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Current Liabilities including historical, tables and charts were last updated by Trading Economics this last November in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $7.55M in Current Assets for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Current Assets including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $-8.33M in Pre-Tax Profit for its fiscal quarter ending in June of 2022. Data for Adamis Pharmaceuticals | ADMP - Pre Tax Profit including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $15.05K in Ordinary Share Capital for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Ordinary Share Capital including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $1.79M in Cost of Sales for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Cost Of Sales including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported 11 in Employees for its fiscal year ending in December of 2022. Data for Adamis Pharmaceuticals | ADMP - Employees Total Number including historical, tables and charts were last updated by Trading Economics this last December in 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $700K in Market Capitalization this April of 2024, considering the latest stock price and the number of outstanding shares.Data for Adamis Pharmaceuticals | ADMP - Market Capitalization including historical, tables and charts were last updated by Trading Economics this last December in 2025.